Skip to main content
Fig. 2 | Molecular Cancer

Fig. 2

From: Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors

Fig. 2

Mutual exclusivity of MED12 mutations, HMGA2 overexpression, and biallelic FH inactivation. Representative figures of uterine smooth muscle tumors with different molecular genetic features. a MED12 mutation-positive conventional leiomyoma, b cellular leiomyoma with HMGA2 overexpression, c 2SC-positive leiomyoma with bizarre nuclei, and d leiomyosarcoma without the known genetic leiomyoma driver aberrations. Antibody stainings are shown with ×40 magnification

Back to article page

Molecular Cancer

ISSN: 1476-4598